Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets.

Tytuł:
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets.
Autorzy:
Gil Gonzalez L; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.
Fernandez-Marrero Y; Biological Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.
Norris PAA; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.; Innovation and Portfolio Management, Canadian Blood Services, Ottawa, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Tawhidi Z; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Shan Y; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.
Cruz-Leal Y; Innovation and Portfolio Management, Canadian Blood Services, Ottawa, ON, Canada.
Won KD; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Frias-Boligan K; Innovation and Portfolio Management, Canadian Blood Services, Ottawa, ON, Canada.
Branch DR; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.; Innovation and Portfolio Management, Canadian Blood Services, Ottawa, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Lazarus AH; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto ON, Canada.; Innovation and Portfolio Management, Canadian Blood Services, Ottawa, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Źródło:
PloS one [PLoS One] 2022 Dec 14; Vol. 17 (12), pp. e0278365. Date of Electronic Publication: 2022 Dec 14 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Receptors, IgG*/metabolism
Immunoglobulin G*
Humans ; THP-1 Cells ; Phagocytosis ; Monocytes/metabolism ; Erythrocytes/metabolism
References:
Haematologica. 2020 Feb 27;106(1):250-254. (PMID: 32107327)
Oncol Rep. 2017 Jan;37(1):408-416. (PMID: 27840999)
Semin Hematol. 2005 Jul;42(3):122-30. (PMID: 16041661)
Front Immunol. 2014 May 30;5:254. (PMID: 24910634)
Haematologica. 2019 Jun;104(6):1237-1243. (PMID: 30923095)
Nat Rev Immunol. 2010 May;10(5):328-43. (PMID: 20414206)
BMC Immunol. 2017 Dec 04;18(1):47. (PMID: 29202702)
J Immunol. 2011 Sep 15;187(6):3208-17. (PMID: 21856937)
Immunol Rev. 2015 Nov;268(1):25-51. (PMID: 26497511)
PLoS One. 2019 Oct 15;14(10):e0223264. (PMID: 31613876)
Adv Immunol. 2007;96:179-204. (PMID: 17981207)
Blood. 2019 Apr 25;133(17):1821-1830. (PMID: 30808636)
Front Immunol. 2019 Mar 27;10:562. (PMID: 30984171)
Eur J Immunol. 2021 May;51(5):1218-1233. (PMID: 33533020)
Mol Immunol. 2020 Nov;127:79-86. (PMID: 32947169)
Best Pract Res Clin Obstet Gynaecol. 2019 Jul;58:15-27. (PMID: 30827816)
Blood. 1998 Mar 1;91(5):1762-8. (PMID: 9473244)
Nat Rev Immunol. 2008 Jan;8(1):34-47. (PMID: 18064051)
J Clin Invest. 1996 Jan 15;97(2):331-8. (PMID: 8567952)
J Biol Chem. 1995 Oct 27;270(43):25762-70. (PMID: 7592758)
Antivir Ther. 2009;14(6):739-49. (PMID: 19812436)
Am J Hematol. 2002 Apr;69(4):258-71. (PMID: 11921020)
Haematologica. 2018 Oct;103(10):1741-1752. (PMID: 29858387)
Cell Immunol. 2018 Oct;332:58-76. (PMID: 30077333)
Front Immunol. 2019 Jan 30;9:3124. (PMID: 30761158)
Int Immunopharmacol. 2014 Nov;23(1):37-45. (PMID: 25130606)
Gene. 1983 Dec;26(1):101-6. (PMID: 6323249)
Front Immunol. 2021 Mar 15;12:594773. (PMID: 33790888)
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12479-84. (PMID: 21746897)
Cell. 2015 May 21;161(5):1035-1045. (PMID: 25976835)
Sci Signal. 2018 Jul 24;11(540):. (PMID: 30042128)
J Immunol. 2009 Feb 15;182(4):2542-50. (PMID: 19201911)
Front Immunol. 2020 Jun 03;11:946. (PMID: 32655543)
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. (PMID: 21997792)
Immunity. 2010 Sep 24;33(3):375-86. (PMID: 20832340)
Blood. 2012 Jun 14;119(24):5640-9. (PMID: 22535666)
BMC Biotechnol. 2011 Oct 12;11:92. (PMID: 21992524)
J Biol Chem. 1985 Sep 15;260(20):11107-14. (PMID: 2411729)
Front Immunol. 2019 Apr 08;10:739. (PMID: 31024565)
Arthritis Rheum. 2004 Jun;50(6):1967-75. (PMID: 15188374)
Immunity. 2002 Mar;16(3):379-89. (PMID: 11911823)
Nat Rev Immunol. 2020 Oct;20(10):633-643. (PMID: 32782358)
J Leukoc Biol. 2007 Mar;81(3):584-92. (PMID: 17135573)
Autoimmun Rev. 2016 Jun;15(6):510-2. (PMID: 26854400)
Immunobiology. 2015 Feb;220(2):193-9. (PMID: 25108563)
Front Immunol. 2014 Oct 17;5:514. (PMID: 25368618)
Annu Rev Immunol. 2001;19:275-90. (PMID: 11244038)
Nitric Oxide. 2021 May 1;109-110:33-41. (PMID: 33667621)
Eur J Immunol. 2008 May;38(5):1414-22. (PMID: 18412163)
Science. 2017 Jan 27;355(6323):395-398. (PMID: 28126818)
J Virol. 2020 Feb 14;94(5):. (PMID: 31826992)
Cold Spring Harb Protoc. 2012 Feb 01;2012(2):199-204. (PMID: 22301656)
J Clin Invest. 1991 Nov;88(5):1766-71. (PMID: 1834702)
Substance Nomenclature:
0 (Receptors, IgG)
0 (Immunoglobulin G)
Entry Date(s):
Date Created: 20221214 Date Completed: 20221216 Latest Revision: 20230110
Update Code:
20240105
PubMed Central ID:
PMC9749970
DOI:
10.1371/journal.pone.0278365
PMID:
36516219
Czasopismo naukowe
Fc gamma receptors (FcγRs) are critical effector receptors for immunoglobulin G (IgG) antibodies. On macrophages, FcγRs mediate multiple effector functions, including phagocytosis, but the individual contribution of specific FcγRs to phagocytosis has not been fully characterized. Primary human macrophage populations, such as splenic macrophages, can express FcγRI, FcγRIIA, and FcγRIIIA. However, there is currently no widely available monocyte or macrophage cell line expressing all these receptors. Common sources of monocytes for differentiation into macrophages, such as human peripheral blood monocytes and the monocytic leukemia cell line THP-1, generally lack the expression of FcγRIIIA (CD16A). Here, we utilized a lentiviral system to generate THP-1 cells stably expressing human FcγRIIIA (CD16F158). THP-1-CD16A cells treated with phorbol 12-myristate 13-acetate for 24 hours phagocytosed anti-D-opsonized human red blood cells primarily utilizing FcγRI with a lesser but significant contribution of IIIA while phagocytosis of antibody-opsonized human platelets equally utilized FcγRI and Fcγ IIIA. Despite the well-known ability of FcγRIIA to bind IgG in cell free systems, this receptor did not appear to be involved in either RBC or platelet phagocytosis. These transgenic cells may constitute a valuable tool for studying macrophage FcγR utilization and function.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2022 Gil Gonzalez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies